HOCCO is on track to close FY26 with ₹450 Cr in revenue, marking a significant scale-up in the brand’s second full year of operations ...
This bioresorbable standard-size pill can be interrogated via RFID to confirm it has been taken by the patient.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results